To determine whether EMT as identified by N-cadherin expression was also related to a specific growth pattern in clinical PCa, we quantified its expression in distinctive PCa growth patterns, as defined by the WHO 2009, in a set of 77 RP specimens (Figure 1) [1-3]. This evidence concerns the gene CDH2 and posterior cortical atrophy.